| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Medical Records Systems, Computerized | 13 | 2020 | 159 | 5.76 | Why? |
| Primary Health Care | 33 | 2021 | 4839 | 3.30 | Why? |
| Medical Informatics | 11 | 2021 | 648 | 2.55 | Why? |
| Electronic Health Records | 13 | 2020 | 3492 | 1.86 | Why? |
| Health Information Exchange | 3 | 2017 | 151 | 1.70 | Why? |
| General Practice | 6 | 2020 | 718 | 1.48 | Why? |
| Biological Ontologies | 2 | 2020 | 77 | 1.46 | Why? |
| Patient Access to Records | 3 | 2018 | 18 | 1.29 | Why? |
| Sentinel Surveillance | 10 | 2020 | 1093 | 1.26 | Why? |
| Cooperative Behavior | 3 | 2018 | 1216 | 1.24 | Why? |
| Information Storage and Retrieval | 3 | 2019 | 644 | 1.11 | Why? |
| England | 22 | 2020 | 5116 | 0.99 | Why? |
| Diabetes Mellitus, Type 2 | 8 | 2019 | 6166 | 0.94 | Why? |
| Influenza, Human | 13 | 2021 | 10779 | 0.88 | Why? |
| Influenza Vaccines | 7 | 2019 | 2941 | 0.85 | Why? |
| Vocabulary, Controlled | 2 | 2018 | 26 | 0.81 | Why? |
| General Practitioners | 4 | 2020 | 568 | 0.78 | Why? |
| Medical Records | 2 | 2019 | 513 | 0.74 | Why? |
| Hypoglycemic Agents | 4 | 2019 | 2165 | 0.73 | Why? |
| Medical Order Entry Systems | 1 | 2018 | 43 | 0.72 | Why? |
| Pancreas, Exocrine | 1 | 2017 | 51 | 0.70 | Why? |
| House Calls | 1 | 2020 | 215 | 0.69 | Why? |
| Clinical Protocols | 2 | 2021 | 2734 | 0.69 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 1261 | 0.68 | Why? |
| Medication Errors | 1 | 2018 | 107 | 0.68 | Why? |
| Public Health Surveillance | 4 | 2020 | 3129 | 0.67 | Why? |
| Health | 1 | 2018 | 130 | 0.65 | Why? |
| Anniversaries and Special Events | 1 | 2018 | 127 | 0.64 | Why? |
| Sodium | 1 | 2018 | 309 | 0.63 | Why? |
| United Kingdom | 21 | 2021 | 18046 | 0.63 | Why? |
| International Agencies | 1 | 2017 | 202 | 0.59 | Why? |
| Medical Errors | 1 | 2018 | 201 | 0.57 | Why? |
| Rare Diseases | 1 | 2018 | 373 | 0.54 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.54 | Why? |
| United Nations | 1 | 2017 | 367 | 0.54 | Why? |
| Disease Notification | 1 | 2020 | 639 | 0.53 | Why? |
| Data Collection | 3 | 2018 | 1769 | 0.53 | Why? |
| Inventions | 1 | 2018 | 372 | 0.53 | Why? |
| Gastroenteritis | 1 | 2018 | 489 | 0.51 | Why? |
| Knowledge | 1 | 2017 | 452 | 0.51 | Why? |
| Diffusion of Innovation | 1 | 2017 | 440 | 0.50 | Why? |
| Population Surveillance | 8 | 2021 | 4967 | 0.49 | Why? |
| Blood Glucose | 5 | 2019 | 3642 | 0.48 | Why? |
| Publications | 1 | 2018 | 463 | 0.48 | Why? |
| Smoking Cessation | 2 | 2018 | 826 | 0.48 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.45 | Why? |
| Child Health | 2 | 2018 | 940 | 0.44 | Why? |
| Renal Insufficiency, Chronic | 4 | 2020 | 2654 | 0.44 | Why? |
| Data Accuracy | 1 | 2016 | 715 | 0.44 | Why? |
| Noncommunicable Diseases | 1 | 2020 | 934 | 0.43 | Why? |
| Blood Banks | 1 | 2017 | 535 | 0.43 | Why? |
| Blood Pressure | 2 | 2020 | 2198 | 0.42 | Why? |
| Humans | 95 | 2021 | 930598 | 0.41 | Why? |
| Respiratory Tract Diseases | 1 | 2017 | 1061 | 0.38 | Why? |
| Pancreatitis | 1 | 2017 | 688 | 0.38 | Why? |
| Diabetes Mellitus, Type 1 | 3 | 2018 | 1969 | 0.37 | Why? |
| Diazepam | 1 | 2008 | 45 | 0.37 | Why? |
| Vaccines, Attenuated | 3 | 2019 | 952 | 0.37 | Why? |
| Information Systems | 1 | 2010 | 110 | 0.37 | Why? |
| Health Records, Personal | 1 | 2009 | 63 | 0.36 | Why? |
| Seasons | 11 | 2021 | 4071 | 0.36 | Why? |
| Influenza B virus | 3 | 2019 | 815 | 0.36 | Why? |
| Physician's Role | 2 | 2017 | 853 | 0.35 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.35 | Why? |
| Patient-Centered Care | 1 | 2016 | 860 | 0.35 | Why? |
| Patient Safety | 3 | 2018 | 4885 | 0.35 | Why? |
| Anti-Anxiety Agents | 1 | 2008 | 139 | 0.34 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.34 | Why? |
| Patient Care | 1 | 2018 | 1664 | 0.33 | Why? |
| Databases, Factual | 3 | 2020 | 6248 | 0.33 | Why? |
| Benzodiazepines | 1 | 2008 | 163 | 0.32 | Why? |
| Patient Care Management | 1 | 2018 | 1514 | 0.32 | Why? |
| Respiratory Tract Infections | 4 | 2021 | 6817 | 0.32 | Why? |
| Glycated Hemoglobin A | 4 | 2018 | 1316 | 0.32 | Why? |
| Chronic Disease | 2 | 2018 | 5139 | 0.32 | Why? |
| Arthritis, Rheumatoid | 1 | 2020 | 2043 | 0.32 | Why? |
| Incidence | 14 | 2021 | 25622 | 0.31 | Why? |
| Family Characteristics | 4 | 2021 | 2551 | 0.31 | Why? |
| Confidentiality | 3 | 2018 | 581 | 0.30 | Why? |
| Influenza A Virus, H3N2 Subtype | 3 | 2019 | 572 | 0.30 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.30 | Why? |
| Health Services Research | 2 | 2020 | 756 | 0.29 | Why? |
| Quality Assurance, Health Care | 1 | 2010 | 596 | 0.28 | Why? |
| Delivery of Health Care | 3 | 2021 | 15909 | 0.27 | Why? |
| Attitude of Health Personnel | 3 | 2018 | 4741 | 0.26 | Why? |
| Diabetes Mellitus | 3 | 2018 | 8207 | 0.26 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.25 | Why? |
| Asthma | 2 | 2019 | 4383 | 0.25 | Why? |
| Aged | 33 | 2021 | 215776 | 0.25 | Why? |
| Male | 38 | 2021 | 367725 | 0.25 | Why? |
| Female | 37 | 2021 | 380317 | 0.25 | Why? |
| Risk Factors | 15 | 2021 | 71621 | 0.24 | Why? |
| Liver Diseases | 1 | 2018 | 2698 | 0.24 | Why? |
| Child | 18 | 2021 | 70012 | 0.23 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.23 | Why? |
| Middle Aged | 31 | 2021 | 270681 | 0.23 | Why? |
| Anti-Bacterial Agents | 2 | 2021 | 10083 | 0.22 | Why? |
| Vaccines, Inactivated | 2 | 2019 | 1562 | 0.22 | Why? |
| Sphygmomanometers | 1 | 2000 | 14 | 0.22 | Why? |
| Telemedicine | 5 | 2021 | 25032 | 0.21 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.21 | Why? |
| Adult | 31 | 2021 | 244371 | 0.21 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.21 | Why? |
| Age Factors | 6 | 2021 | 21039 | 0.21 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.21 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.21 | Why? |
| Risk Management | 2 | 2018 | 1044 | 0.21 | Why? |
| Vaccination | 6 | 2019 | 19050 | 0.21 | Why? |
| Follow-Up Studies | 5 | 2020 | 17020 | 0.20 | Why? |
| Infant | 13 | 2021 | 30274 | 0.20 | Why? |
| Child, Preschool | 12 | 2020 | 36283 | 0.20 | Why? |
| Aged, 80 and over | 18 | 2021 | 88759 | 0.20 | Why? |
| Prescriptions | 1 | 2021 | 258 | 0.20 | Why? |
| Vaccine Potency | 2 | 2018 | 339 | 0.20 | Why? |
| Palpation | 1 | 2018 | 16 | 0.19 | Why? |
| Budesonide | 1 | 2021 | 192 | 0.19 | Why? |
| Medical Record Linkage | 1 | 2018 | 58 | 0.19 | Why? |
| Quality Improvement | 3 | 2018 | 2435 | 0.19 | Why? |
| Sex Factors | 3 | 2020 | 11014 | 0.19 | Why? |
| Insulin | 2 | 2018 | 1316 | 0.19 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.18 | Why? |
| Doxycycline | 1 | 2021 | 307 | 0.18 | Why? |
| Cross-Sectional Studies | 8 | 2020 | 53120 | 0.18 | Why? |
| Neuralgia, Postherpetic | 1 | 2017 | 22 | 0.18 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.18 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.18 | Why? |
| Injections | 1 | 2019 | 237 | 0.18 | Why? |
| Sulfonylurea Compounds | 1 | 2018 | 79 | 0.17 | Why? |
| Eye Infections | 1 | 2017 | 20 | 0.17 | Why? |
| Semantics | 1 | 2018 | 104 | 0.17 | Why? |
| Retrospective Studies | 12 | 2021 | 105322 | 0.17 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.17 | Why? |
| Neisseria meningitidis, Serogroup B | 1 | 2017 | 66 | 0.17 | Why? |
| Holistic Health | 1 | 2018 | 90 | 0.17 | Why? |
| Ergocalciferols | 1 | 2017 | 51 | 0.17 | Why? |
| Poisson Distribution | 1 | 2018 | 348 | 0.17 | Why? |
| Phosphates | 1 | 2017 | 135 | 0.17 | Why? |
| Government Programs | 2 | 2020 | 512 | 0.17 | Why? |
| Delphi Technique | 2 | 2020 | 1257 | 0.17 | Why? |
| Europe | 6 | 2021 | 12702 | 0.16 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.16 | Why? |
| Blood Pressure Monitoring, Ambulatory | 1 | 2000 | 341 | 0.16 | Why? |
| Prevalence | 5 | 2019 | 25773 | 0.16 | Why? |
| Meningitis, Meningococcal | 1 | 2017 | 114 | 0.16 | Why? |
| Cardiovascular Diseases | 2 | 2018 | 11497 | 0.16 | Why? |
| Clinical Coding | 1 | 2018 | 172 | 0.16 | Why? |
| Herpes Zoster Vaccine | 1 | 2017 | 112 | 0.16 | Why? |
| Enterovirus D, Human | 1 | 2017 | 96 | 0.16 | Why? |
| Young Adult | 15 | 2021 | 93724 | 0.16 | Why? |
| Physician Assistants | 1 | 2017 | 115 | 0.15 | Why? |
| Australia | 2 | 2021 | 6306 | 0.15 | Why? |
| Smoking | 2 | 2020 | 3358 | 0.15 | Why? |
| Anxiety Disorders | 1 | 2008 | 2290 | 0.15 | Why? |
| Public Health Informatics | 1 | 2017 | 155 | 0.15 | Why? |
| Organizational Objectives | 1 | 2017 | 180 | 0.14 | Why? |
| Focus Groups | 1 | 2019 | 811 | 0.14 | Why? |
| Poverty Areas | 1 | 2020 | 556 | 0.14 | Why? |
| Uveitis | 1 | 2018 | 233 | 0.14 | Why? |
| Health Occupations | 1 | 2018 | 235 | 0.14 | Why? |
| Acute Disease | 2 | 2018 | 6029 | 0.14 | Why? |
| Malpractice | 1 | 2018 | 165 | 0.14 | Why? |
| Meningococcal Vaccines | 1 | 2017 | 225 | 0.14 | Why? |
| Body Mass Index | 2 | 2019 | 4306 | 0.14 | Why? |
| Case-Control Studies | 5 | 2021 | 17671 | 0.14 | Why? |
| Checklist | 1 | 2020 | 714 | 0.14 | Why? |
| Mental Health | 1 | 2021 | 15770 | 0.14 | Why? |
| Adolescent | 16 | 2021 | 86841 | 0.14 | Why? |
| Proteinuria | 1 | 2018 | 474 | 0.14 | Why? |
| Professionalism | 1 | 2017 | 171 | 0.14 | Why? |
| Respiratory Syncytial Virus Infections | 2 | 2021 | 1234 | 0.14 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2019 | 2984 | 0.13 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2021 | 846 | 0.13 | Why? |
| Cholecalciferol | 1 | 2017 | 246 | 0.13 | Why? |
| Academies and Institutes | 1 | 2017 | 539 | 0.13 | Why? |
| Age Distribution | 3 | 2019 | 3567 | 0.13 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.13 | Why? |
| Diabetic Retinopathy | 1 | 2018 | 347 | 0.13 | Why? |
| Health Planning | 1 | 2020 | 607 | 0.12 | Why? |
| Immunization Programs | 4 | 2018 | 2006 | 0.12 | Why? |
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 645 | 0.12 | Why? |
| Societies, Medical | 2 | 2020 | 6907 | 0.12 | Why? |
| Databases, Genetic | 1 | 2018 | 1127 | 0.12 | Why? |
| Qualitative Research | 3 | 2020 | 4337 | 0.12 | Why? |
| Quality Indicators, Health Care | 1 | 2018 | 580 | 0.12 | Why? |
| Herpes Zoster | 1 | 2017 | 331 | 0.12 | Why? |
| Computer Security | 1 | 2016 | 408 | 0.12 | Why? |
| Enterovirus Infections | 1 | 2017 | 404 | 0.12 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 694 | 0.12 | Why? |
| Protective Factors | 1 | 2018 | 1720 | 0.12 | Why? |
| Access to Information | 1 | 2016 | 483 | 0.11 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.11 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2018 | 669 | 0.11 | Why? |
| Comorbidity | 4 | 2020 | 34796 | 0.11 | Why? |
| Health Services | 1 | 2018 | 765 | 0.11 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.11 | Why? |
| Metformin | 1 | 2018 | 640 | 0.11 | Why? |
| Models, Organizational | 1 | 2017 | 908 | 0.11 | Why? |
| Risk Reduction Behavior | 1 | 2018 | 946 | 0.11 | Why? |
| Privacy | 1 | 2016 | 636 | 0.11 | Why? |
| Mass Vaccination | 1 | 2021 | 1101 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Research Design | 2 | 2017 | 5830 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.10 | Why? |
| Technology | 1 | 2016 | 812 | 0.10 | Why? |
| Cerebral Hemorrhage | 1 | 2018 | 820 | 0.10 | Why? |
| Science | 1 | 2017 | 463 | 0.10 | Why? |
| Internet | 3 | 2018 | 6204 | 0.10 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.10 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.10 | Why? |
| Time Factors | 5 | 2020 | 31397 | 0.10 | Why? |
| Patient Acceptance of Health Care | 1 | 2008 | 5002 | 0.10 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.09 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.09 | Why? |
| Hemorrhage | 1 | 2021 | 3013 | 0.09 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.09 | Why? |
| Obesity | 2 | 2020 | 7388 | 0.09 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.09 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.09 | Why? |
| Vitamins | 1 | 2017 | 1208 | 0.09 | Why? |
| Workload | 1 | 2018 | 1887 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.09 | Why? |
| Canada | 1 | 2021 | 6018 | 0.09 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.09 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.09 | Why? |
| Rural Population | 1 | 2020 | 2408 | 0.08 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.08 | Why? |
| Professional Role | 1 | 2017 | 1280 | 0.08 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.08 | Why? |
| Biomedical Research | 2 | 2018 | 5270 | 0.08 | Why? |
| Scotland | 2 | 2021 | 1119 | 0.08 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.08 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.08 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.08 | Why? |
| Medical History Taking | 1 | 2008 | 350 | 0.08 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.08 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.08 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.08 | Why? |
| Pregnant Women | 1 | 2019 | 2535 | 0.08 | Why? |
| Anemia | 1 | 2013 | 789 | 0.07 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.07 | Why? |
| Influenza A virus | 1 | 2017 | 2234 | 0.07 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.07 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.07 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.07 | Why? |
| Fever | 2 | 2020 | 7795 | 0.07 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.07 | Why? |
| Health Policy | 2 | 2021 | 6242 | 0.07 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.07 | Why? |
| Vitamin D Deficiency | 1 | 2017 | 1782 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.06 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.06 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.06 | Why? |
| Minimal Clinically Important Difference | 1 | 2021 | 39 | 0.06 | Why? |
| Decision Making | 1 | 2016 | 3132 | 0.06 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.06 | Why? |
| Family Practice | 1 | 2008 | 472 | 0.06 | Why? |
| Surveys and Questionnaires | 3 | 2018 | 43792 | 0.06 | Why? |
| Self Care | 1 | 2010 | 918 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.05 | Why? |
| Iceland | 1 | 2021 | 314 | 0.05 | Why? |
| Healthcare Disparities | 1 | 2018 | 3893 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Wrist | 1 | 2000 | 37 | 0.05 | Why? |
| Physicians, Family | 1 | 2003 | 208 | 0.05 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.05 | Why? |
| Quality of Health Care | 1 | 2012 | 1948 | 0.05 | Why? |
| Intention to Treat Analysis | 1 | 2021 | 673 | 0.05 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.05 | Why? |
| Confusion | 1 | 2020 | 256 | 0.05 | Why? |
| Effect Modifier, Epidemiologic | 1 | 2018 | 39 | 0.05 | Why? |
| Registries | 1 | 2018 | 12327 | 0.05 | Why? |
| Physician-Patient Relations | 1 | 2008 | 1266 | 0.04 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.04 | Why? |
| Administration, Ophthalmic | 1 | 2017 | 53 | 0.04 | Why? |
| Food, Fortified | 1 | 2017 | 43 | 0.04 | Why? |
| Odds Ratio | 2 | 2020 | 5861 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.04 | Why? |
| Time | 1 | 2019 | 631 | 0.04 | Why? |
| Infant, Newborn | 4 | 2019 | 23105 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Secondary Care | 1 | 2017 | 160 | 0.04 | Why? |
| Decision Support Techniques | 1 | 2003 | 903 | 0.04 | Why? |
| Manikins | 1 | 2018 | 466 | 0.04 | Why? |
| Wales | 1 | 2018 | 758 | 0.04 | Why? |
| Administration, Inhalation | 1 | 2021 | 1647 | 0.04 | Why? |
| Sinus Thrombosis, Intracranial | 1 | 2021 | 550 | 0.04 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.04 | Why? |
| Myalgia | 1 | 2020 | 1015 | 0.03 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2019 | 14232 | 0.03 | Why? |
| Diagnosis, Differential | 1 | 2009 | 7220 | 0.03 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.03 | Why? |
| Serum Albumin | 1 | 2017 | 571 | 0.03 | Why? |
| United States | 1 | 2021 | 46150 | 0.03 | Why? |
| Warfarin | 1 | 2018 | 402 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2019 | 11559 | 0.03 | Why? |
| Predictive Value of Tests | 1 | 2009 | 9537 | 0.03 | Why? |
| Nurse Practitioners | 1 | 2017 | 248 | 0.03 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.03 | Why? |
| Viral Fusion Proteins | 1 | 2017 | 399 | 0.03 | Why? |
| Morbidity | 1 | 2019 | 1426 | 0.03 | Why? |
| Schools | 2 | 2019 | 4187 | 0.03 | Why? |
| Atherosclerosis | 1 | 2020 | 768 | 0.03 | Why? |
| Social Class | 1 | 2021 | 1360 | 0.03 | Why? |
| Sex Distribution | 1 | 2019 | 2083 | 0.03 | Why? |
| Robotics | 1 | 2018 | 528 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Algorithms | 1 | 2009 | 7346 | 0.03 | Why? |
| Heart Rate | 1 | 2020 | 1527 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.03 | Why? |
| Asia | 1 | 2017 | 2399 | 0.03 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.02 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.02 | Why? |
| Self Report | 1 | 2021 | 3802 | 0.02 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.02 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.02 | Why? |
| Health Personnel | 1 | 2018 | 29646 | 0.02 | Why? |
| Inservice Training | 1 | 2012 | 477 | 0.02 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2000 | 2517 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Practice Guidelines as Topic | 1 | 2008 | 15421 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2019 | 10017 | 0.02 | Why? |
| State Medicine | 1 | 2017 | 2847 | 0.02 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Patient Compliance | 1 | 2012 | 1468 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.01 | Why? |
| Neoplasms | 1 | 2003 | 17251 | 0.01 | Why? |
| Ambulatory Care | 1 | 2012 | 4947 | 0.01 | Why? |